Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Sunrest Lifescience

Market Cap: ₹202.5m

Manufactures, sells, and markets healthcare products, medicines, and cosmetic products in India.

PharmaTher Holdings

Market Cap: CA$34.1m

A specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes.

Navamedic

Market Cap: NOK 379.7m

A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.

Acumen Pharmaceuticals

Market Cap: US$89.6m

A clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer’s disease.

Celyad Oncology

Market Cap: €13.8m

A biotechnology company, focuses on the research and development of chimeric antigen receptor T cell (CAR T) therapies for cancer.

Alpha Cognition

Market Cap: US$124.8m

A biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada.

Crinetics Pharmaceuticals

Market Cap: US$3.4b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Genprex

Market Cap: US$7.9m

A clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes.

ALT5 Sigma

Market Cap: US$382.3m

Provides blockchain-powered technologies worldwide.

Q/C Technologies

Market Cap: US$8.3m

A clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets.

Poltreg

Market Cap: zł117.5m

A biotechnology company, researches and develops therapies for autoimmune diseases.

Moberg Pharma

Market Cap: SEK 400.0m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.

Myriad Genetics

Market Cap: US$722.0m

A molecular diagnostic testing and precision medicine company, develops and provides molecular tests.

Auxly Cannabis Group

Market Cap: CA$202.3m

Operates as a consumer packaged goods company in the cannabis products market in Canada.

Nuvalent

Market Cap: US$5.6b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

Ocular Therapeutix

Market Cap: US$2.1b

A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.

Organogenesis Holdings

Market Cap: US$593.7m

A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.

InnoCan Pharma

Market Cap: CA$84.5m

A pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally.

60 Degrees Pharmaceuticals

Market Cap: US$5.7m

A specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States.

Sangamo Therapeutics

Market Cap: US$191.0m

A clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.

Actinium Pharmaceuticals

Market Cap: US$49.6m

Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.

Neovacs

Market Cap: €80.9k

A biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France.

Alector

Market Cap: US$296.6m

A late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases.

Personalis

Market Cap: US$530.3m

Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.

Celcuity

Market Cap: US$2.2b

A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.

Medicus Pharma

Market Cap: US$48.2m

A biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets.

Apimeds Pharmaceuticals US

Market Cap: US$22.4m

Operates as a clinical stage biopharmaceutical company in the United States.

Faes Farma

Market Cap: €1.3b

Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide.

ChemoMetec

Market Cap: DKK 10.8b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

Laboratorios Farmaceuticos Rovi

Market Cap: €2.9b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Camp4 Therapeutics

Market Cap: US$60.5m

A clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases.

Pliant Therapeutics

Market Cap: US$88.4m

A biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases.

Twist Bioscience

Market Cap: US$1.6b

Manufactures and sells synthetic DNA-based products.

CRISPR Therapeutics

Market Cap: US$5.5b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Recursion Pharmaceuticals

Market Cap: US$2.0b

Operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States.

iBio

Market Cap: US$15.7m

A preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space.